HTATIP2 and neoplasm: Taken together, the data demonstrated that the absent expression of HTATIP2 in A549 cells resulted in an aggressive tumor phenotype, marked by rapid growth, poor oxygenation and decreased sensitivity to sorafenib treatment, which was not attributable to the decreased sorafenib distribution in tumor.